FOXO1 Overexpression Attenuates Tubulointerstitial Fibrosis and Apoptosis in Diabetic Kidneys by Ameliorating Oxidative Injury via TXNIP-TRX

Table 2

Body weight, kidney weight/body weight ratio, and biochemical indicators in the normal, diabetic (DM), and Foxo1 transgenic diabetic (Tg DM) groups at week 12 after injection.

Group		BW (g)	KI (×10-3)	BG (mmol/L)	UTP (mg)	Scr (μmol/L)	Urea (mmol/L)
NG	9
DM	9
Tg DM	9

The data are displayed as the errors. BW, body weight; KI, kidney weight/body weight ratio; BG, blood glucose; UTP, 24 h urinary total protein; Scr, serum creatinine. vs. the normal group. vs. the DM group.